Bioventus Class A Inc (BVS)

R&D Expenses

$3.17M

Quarterly · Period ending: · USD

BVS logo

BVS R&D Expenses

Latest reported$3.17M
BVS Quarterly R&D Expenses ($2.97M → $3.17M)
High-resolution chart · PNG

BVS r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bioventus Class A Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
3,173,000
2,467,000
3,007,000
2,923,000
3,172,000
3,011,000
3,246,000
3,808,000
4,210,000
2,627,000
3,262,000
3,015,000
3,398,000
3,771,000
6,807,000
4,614,000
6,366,000
6,928,000
7,103,000
6,153,000
4,836,000
947,000
2,891,000
3,569,000
2,596,000
2,146,000
2,845,000
2,531,000
2,531,000
3,718,000
2,966,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.